hepatitis B

Dicerna guides Roche-partnered hepatitis B drug past early test
Fierce Biotech
Thu, 08/6/20 - 10:15 am
Roche
Dicerna Pharmaceuticals
hepatitis B
RG6346
clinical trials
Roche drops hep B antiviral as late-stage pipeline tests 'largely on track' despite COVID-19 disruption
Fierce Biotech
Thu, 07/23/20 - 11:12 am
Roche
antiviral
hepatitis B
RG6217
BeiGene expands pipeline and hops on board a quest to cure hep B, inking a $540M deal with a fellow upstart biotech
Endpoints
Mon, 07/20/20 - 10:29 am
China
BeiGene
Assembly Biosciences
hepatitis B
Biotech Gilead axes $445M Precision Biosciences gene therapy hep B pact
Fierce Biotech
Wed, 07/8/20 - 10:39 am
Gilead Sciences
Precision Biosciences
hepatitis B
R&D
Is Arrowhead Pharmaceuticals Close to a Cure for HBV?
Motley Fool
Thu, 04/30/20 - 10:30 am
Arrowhead Pharmaceuticals
hepatitis B
Vir reminds biopharma its original aim is hepatitis B
BioPharma Dive
Thu, 04/16/20 - 11:41 pm
Vir Biotechnology
hepatitis B
VIR-2218
clinical trials
Upcoming events – Soleno has a date with Destiny while Arbutus tries again
EP Vantage
Fri, 02/28/20 - 10:42 am
Solena
diazoxide choline
Prader-Willi Syndrome
Arbutus
hepatitis B
ARB-729
Patient dies in a troubled HBV drug program — forcing developers to scrap the drug and shift focus
Endpoints
Wed, 01/29/20 - 10:31 am
hepatitis B
Spring Bank Pharmaceuticals
clinical trials
patient deaths
inarigivir soproxil
Spring Bank Pharma shares slide 45% premarket after it halts trial of treatment for hepatitis B virus
Marketwatch
Mon, 12/30/19 - 10:37 am
Spring Bank Pharmaceuticals
hepatitis B
clinical trials
FDA
inarigivir soproxil
AASLD 2019 – Assembly asks investors to keep the faith
EP Vantage
Thu, 11/14/19 - 10:15 am
AASLD
Assembly Biosciences
hepatitis B
ABI-H0731
Roche pays $200M for rights to Dicerna's hepatitis B RNAi drug
Fierce Biotech
Thu, 10/31/19 - 10:29 am
Roche
Dicerna Pharmaceuticals
RNAi
hepatitis B
DCR-HBVS
Two acute cases of liver disease in healthy subjects kill Arbutus' hep B program
Endpoints
Fri, 10/4/19 - 10:32 am
Arbutus BioPharma
hepatitis B
clinical trials
Vivek Ramaswamy
AB-506
GSK licenses Ionis' midphase hepatitis B program for $25M
Fierce Biotech
Tue, 08/27/19 - 09:51 am
GSK
Ionis Pharmaceuticals
antisense
hepatitis B
Busy Gilead crew throws struggling biotech a lifeline, with some cash upfront and hundreds of millions in biobucks for HIV deal
Endpoints
Mon, 07/22/19 - 10:08 am
Gilead Sciences
Durect
HIV
hepatitis B
extended release
VBI hepatitis B vaccine meets main goals in late-stage trial
Yahoo/Reuters
Mon, 06/17/19 - 09:55 am
VBI Vaccines
hepatitis B
vaccines
GSK
Engerix-B
Sci-B-Vac
clinical trials
Here's Why Arrowhead Pharmaceuticals Surged 31.9% in May
Motley Fool
Tue, 06/11/19 - 09:39 am
Arrowhead Pharmaceuticals
clinical trials
JNJ
hepatitis B
Arrowhead starts triple-combo hepatitis B test, triggering J&J payday
Fierce Biotech
Wed, 04/24/19 - 11:53 am
Arrowhead Pharmaceuticals
JNJ
clinical trials
hepatitis B
ARO-HBV
Sanofi and Merck Snag FDA Approval for a Six-Disease Combination Vaccine
BioSpace
Thu, 12/27/18 - 10:22 pm
vaccines
FDA
Vaxelis
diphtheria
tetanus
pertussis
polio
hepatitis B
haemophilus influenza type b
Sanofi
Merck
Here's Why Arrowhead Pharmaceuticals Jumped 14.1% in November
Motley Fool
Mon, 12/10/18 - 07:04 pm
Arrowhead Pharmaceuticals
ARO-HBV
hepatitis B
Janssen
RNAi
CEO of Chapel Hill firm talks 2 new partnerships with big pharma
Bizjournals
Sat, 12/8/18 - 10:31 am
Target PharmaSolutions
Gilead Sciences
Bristol-Myers Squibb
hepatitis B
NASH

Pages